Exploring the modernization process of traditional medicine: a Triple Helix perspective with insights from publication and trademark statistics

Abstract

French

The traditional medicine industry has undergone rapid modernization in the last 20 years, spurred on by the World Health Organization’s (WHO) Traditional Medicine Agenda to integrate traditional medicine as a complement to conventional Western medicine. While the current literature tends to visualize traditional medical systems in silos within the context of their own national interests, we aim to evaluate and explore the changing innovation landscape in traditional medicine across several selected Asian economies in order to provide a snapshot of capability in this rapidly growing field of study. Adopting an evolutionary perspective of industrial progress, this study utilizes data relating to scientific publications and trademarks to indicate the trajectory of knowledge production and commercialization in traditional medicine, and thus to assess the modernization efforts of the selected economies. For this study, we observe innovative activity in China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand between 1993 and 2012. The results show that Hong Kong, China, Taiwan, and South Korea have the most sophisticated innovation systems in terms of capability and productivity in the fields of science and innovation. Japan and Singapore have also shown strong growth, while Thailand and Malaysia are lagging behind the other selected economies.

Keywords

Asia evolutionary perspective innovation modernization publications trademarks traditional medicine Triple Helix

Get full access to this article

View all access options for this article.

References

Chen

(2012) Cooperative innovation in the Chinese biotechnology industry: An analysis based on Chinese and US patents from 2000 to 2007. In: Assimakopoulos

Karayannis

Dossani

(eds) Knowledge Perspectives of New Product Development: A comparative approach. New York, NY: Springer, 271–273.

Cheung

(2011) TCM: Made in China. Nature 480: 82–83.

Chi

Lee

Lai

Chen

. (1996) The practice of Chinese medicine in Taiwan. Social Science & Medicine 43(9): 1329–1348.

China Medical University (2014) Overview. Available at: http://english.cmu.edu.tw/about/overview.php. (accessed 27 March 2014)

Chinese Medicine Division (2010) Development of Chinese Medicine in Hong Kong. Available at: http://www.cmd.gov.hk/html/eng/development/development.html. (accessed 29 March 2014)

Chung

VCH

Hillier

Lau

Wong

SYS

. (2011) Referral to and attitude towards traditional Chinese medicine amongst Western medical doctors in postcolonial Hong Kong. Social Science & Medicine 72(2): 247–255.

CUHK (2014) Institute of Chinese Medicine. Available at: http://www.cuhk.edu.hk/icm/en/index.htm. (accessed 28 April 2014)

Dodgson

(2009) Asia’s national innovation systems: Institutional adaptability and rigidity in the face of global innovation challenges. Asia Pacific Journal of Management 26: 589–609.

Engebretson

(2002) Culture and complementary therapies. Complementary Therapies Nursing and Midwifery 8: 177–184.

10.

Etzkowitz

(2003) Innovation in innovation: The Triple Helix of University–Industry–Government relations. Social Science Information 42(3): 293–337.

11.

Geels

(2004) From sectoral systems of innovation to socio-technical systems: Insights about dynamics and change from sociology and institutional theory. Research Policy 33: 897–920.

12.

Greenhalgh

Robert

Macfarlane

Bate

. (2005) Storylines of research in diffusion of innovation: A meta-narrative approach to systematic review. Social Science & Medicine 61: 417–430.

13.

Hesketh

Zhu

(1997) Health in China: Traditional Chinese medicine. One country, two systems. British Medical Journal 315(7100): 115–117.

14.

Holliday

(2003) Traditional medicines in modern societies: An exploration of integrationist options through East Asian experience. Journal of Medicine and Philosophy 28(3): 373–389.

15.

Hong

(2001) Complementary and alternative medicine in Korea: Current status and future prospects. Journal of Alternative and Complementary Medicine 7(1): 33–40.

16.

Rousseau

Chen

(2011) On the definition of forward and backward citation generations. Journal of Informetrics 5: 27–36.

17.

Innovation and Technology Fund HK (2014) Distribution of Approved Projects among Different Technology Areas. Available at: http://www.itf.gov.hk/l-eng/StatView107.asp. (accessed 26 March 2014)

18.

Institute of Natural Medicine (2014) Homepage. Available at: http://www.inm.u-toyama.ac.jp/index-e.html. (accessed 1 April 2014)

19.

Institute of Technological Research and Innovation Taiwan (2014) Pharmaceutical Technologies. Available at: https://www.itri.org.tw/eng/econtent/research/research07_02.aspx?sid=30. (accessed 26 March 2014)

20.

International Agency for Research on Cancer (2002) Some traditional herbal medicines, some mycotoxins, naphthalene, and styrene. IARC Monographs 82: 43–68. Available at: http://monographs.iarc.fr/ENG/Monographs/vol82/mono82.pdf.

21.

Järvenpää

Mäkinen

Seppänen

(2011) Patent and publishing activity over a technology’s life cycle. Technological Forecasting & Social Change 78: 283–293.

22.

King

(2004) The scientific impact of nations. Nature 430: 311–316.

23.

Kyung Hee University (2009) Introduction of OM. Available at: http://eng.kyunghee.or.kr/02/01.php. (accessed 27 March 2014)

24.

Lagendijk

(2003) Towards conceptual quality in regional studies: The need for subtle critique – The response to Markusen. Regional Studies 37: 719–727.

25.

Lazzeretti

Sedita

Caloffi

(2014) Founders and disseminators of cluster research. Journal of Economic Geography 14: 21–43.

26.

Leydesdorff

Etzkowitz

(1998) Emergence of a Triple Helix of university–industry–government relations. Science & Public Policy 23: 279–286.

27.

May

(1997) The scientific wealth of nations. Science 275(5301): 793–796.

28.

Mendonca

Pereira

Godinho

(2004) Trademarks as an indicator of innovation and industrial change. Research Policy 33: 1385–1404.

29.

Ministry of Public Health (2005) Health Policy in Thailand. Available at: http://bps.ops.moph.go.th/webenglish/HealthPolicy5.pdf. (accessed 16 April 2014)

30.

PEMANDU (2010) Economic Transformation Programme. Available at: http://etp.pemandu.gov.my/About_ETP-@-Overview_of_ETP.aspx. (accessed 16 April 2014)

31.

Quah

(2003) Traditional healing systems and the ethos of science. Social Science & Medicine 57(10): 1997–2012.

32.

Schmoch

(2007) Double-boom cycles and the comeback of science-push and market-pull. Research Policy 36: 1000–1005.

33.

Shen

Chen

. (1997) Use of arsenic trioxide (AS2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89: 3354–3360.

34.

Shiu

Wong

(2013) The dynamic effect of knowledge capitals in the public research institute: Insights from patenting analysis of ITRI (Taiwan) and ETRI (Korea). Scientometrics DOI10.1007/s11192–013–1158–6.

35.

TCMPB (2011) About TCMPB. Available at: http://www.healthprofessionals.gov.sg/content/hprof/tcmpb/en/topnav/about_tcmpb.html. (accessed 30 April 2014)

36.

Teubal

(1997) A catalytic and evolutionary approach to horizontal technology policies (HTPs). Research Policy 25: 1167–1188.

37.

Tsumura & Co. (2011) Tsumura & Co. Available at: http://www.tsumura.co.jp/English/index.htm. (accessed 1 April 2014)

38.

. (2011) The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nature Medicine 17: 1217–1220.

39.

Tyler

(2000) Herbal medicine: From the past to the future. Public Health and Nutrition 3: 445–447.

40.

United States Patent and Trademark Office (2011) General Information Concerning Patents. Available at: http://www.uspto.gov/patents/resources/general_info_concerning_patents.pdf. (accessed 6 March 2014)

41.

Wall

Wani

Cook

Palmer

. (1966) Plant antitumor agents I: The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumour inhibitor from Camptotheca acuminata. Journal of the American Chemical Society 88: 3888–3890.

42.

Weber

Rohracher

(2012) Legitimizing research, technology and innovation policies for transformative change: Combining insights from innovation systems and multi-level perspective in a comprehensive ‘failures’ framework. Research Policy 41: 1037–1047.

43.

WIPO Resources (2014) Global Brand Database. Available at: http://www.wipo.int/branddb/en/. (accessed 30 April 2014)

44.

Wong

C-Y

M-C

Shiu

J-W

(2015) Governing the economic transition: How Taiwan strategically transformed its industrial system to attain virtuous cycle development. Review of Policy Research. (forthcoming)

45.

World Bank (2014) Population total. http://data.worldbank.org/indicator/SP.POP.TOTL. (accessed: 29 April 2014)

46.

World Health Organization (2005) Traditional Medicine. Available at: http://www.who.int/topics/traditional_medicine/en/. (accessed 11 February 2014)

47.

World Health Organization (2012) Regional Progress in Traditional Medicine 2010–2011. Available at: http://www.wpro.who.int/traditional_medicine/data/en/index.html. (accessed 17 February 2014)

48.

World Intellectual Property Organization (2014) Background Brief: Intellectual property and traditional medical knowledge. Available at: http://www.wipo.int/export/sites/www/tk/en/resources/pdf/tk_brief6.pdf. (accessed 6 March 2014)

49.

Bauer

Hendry

Fan

. (2013) The quest for modernization of traditional Chinese medicine. BMC Complementary and Alternative Medicine 13: 132.

50.

Xutian

Zhang

Louise

(2009) New exploration and understanding of traditional Chinese medicine. American Journal of Chinese Medicine 37: 411–426.